Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ChronoScale Holdings CorpEKSO · Entity 4331 | Vice Pres., Global Marketing | March 22, 2018 | March 27, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ChronoScale Holdings Corp
Report date March 22, 2018 · Filed March 27, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,235 |
Ending reported balance
After 2018-03-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-03-22 · Grant · Acquired 22,632 · Balance 25,890 Row 2 · 2018-03-23 · Tax withholding · Disposed 8,655 · Balance 17,235 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.54, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.54, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2018 Filed Mar 27, 2018 17:16 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | Tax withholdingCommon Stock | 8,655 | $1.53 | $13,199.74 |
DisclosureSEC source: 0001209191-18-021773 · doc4.xml · nonDerivative · entry 2 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,235 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.54, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| March 22, 2018 Filed Mar 27, 2018 17:16 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 22,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021773 · doc4.xml · nonDerivative · entry 1 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,890 Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 18:21 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | OtherSubscription Rights (right to buy) · Derivative | 1,429 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001455244-17-000034 · edgar.xml · derivative · entry 2 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,829 shares Expires 2017-08-31 Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 18:21 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | OtherCommon Stock | 1,829 | $1.00 | $1,829.00 |
DisclosureSEC source: 0001455244-17-000034 · edgar.xml · nonDerivative · entry 1 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,258 F1 · shares: On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights. F2 · shares: The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 1,658 shares of common stock. The reporting person also exercised 148 of his over-subscription rights for an additional 171 shares of common stock. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 19:29 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001578259-17-000018 · edgar.xml · derivative · entry 2 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Ekso Bionics Holdings, Inc. common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning on the one year anniversary of the date of grant. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| April 20, 2017 Filed Apr 24, 2017 19:29 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantEmployee Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001578259-17-000018 · edgar.xml · derivative · entry 1 Davault Gregory · CIK 0001694979 · Vice Pres., Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-04-20 F1 · derivative.exercise_date: The option becomes exercisable as to 25% of the total number of shares on the one year anniversary of the date of grant and thereafter vests in equal monthly installments for 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.